Svetlana Dali, convicted in 2024 for flying to Paris without a passport or ticket, was taken into custody Thursday at Milan’s Malpensa Airport, said the official, who was not authorized to disclose ...
SEATTLE (AP) — Hilary Knight doesn't want to let what she called a “distasteful” joke by President Donald Trump about the ...
Sen. Bill Cassidy (R-Louisiana), who leads the Senate’s health panel, commits to holding a hearing to discuss the rising costs of medicine as Sen. Bernie Sanders (I-Vermont) makes a push for a ...
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone ...
It’s not only high-ranking Republicans who are wary about locating a detention center in their back yard. Local politicians ...
Republicans and Democrats clashed Wednesday at the state Capitol over emergency legislation on a wide variety of subjects, ...
Burger King is testing AI-powered headsets that can recite recipes, alert managers when inventories are low and even track ...
Nearly half all U.S. states prohibit certain people on probation from accessing SNAP benefits.
Learn more about whether Celldex Therapeutics, Inc. or Zai Lab Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether Celldex Therapeutics, Inc. or Catalyst Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
The study published in NEJM entitled, “Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated Tumors,” highlighted the antitumor activity of rezatapopt in heavily pretreated patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results